Maintenance Venetoclax in AML Fit Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
this study will explore the efficacy of maintenance SC cytarabine + venetoclax therapy as regard disease free survival (DFS) in AML fit patients who achieved CR after highly aggressive chemotherapy as bridge for BMT or if BMT will be delayed or canceled due to any other reason.
Epistemonikos ID: 3c5484a26cb008a23999bd48982e8a4ffc72e6c4
First added on: Nov 25, 2025